Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
Clinical trial NCT03836014 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03836014
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-25
- Primary completion
- 2026-07-01
- Enrollment
- 436
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.